semaglutide gastrointestinal side effects Lawsuit filed against makers of Ozempic and Mounjaro Ozempic Use Can Result in

Donating after you've reached your target dose and any initial side effects have resolved reduces the risk of feeling faint or experiencing delayed reactions post-donation

Additional reasons for deferral include: Diabetes-related complications affecting the heart, kidneys, eyes, peripheral nerves, or circulation Recent hospital admission or significant illness Unstable diabetes control or recent treatment changes Concurrent serious medical conditions Donors must also meet standard eligibility criteria regarding age (17 years or older

In April 2026, the FDA approved semaglutide 7.2 mg (Wegovy HD) under an accelerated review process

Larrivo effettivo in farmacia in Italia quindi plausibile verso la fine del 2026/inizio 2027, fermo restando che il calendario esatto dipende dalle decisioni regolatorie in corso